In a clinical laboratory, clinical pathology tests are carried out on collected clinical specimens, for obtaining information about the patient’s health, in order to aid in diagnosis, prevention, and treatment of diseases. The role of good quality management system is highly important to meet the international standards. This market in Nigeria is mainly driven by the growing burden of chronic diseases and increasing demand for accurate disease diagnosis, along with the government’s focus on public-private partnerships. However, factors, such as lack of medical laboratories, advanced diagnostic equipment, and inadequately trained laboratory staff are restraining the market’s growth.

The report provides market dynamics and trends related to the global companion diagnostics market. In addition, it presents the market estimations and forecast of the market. The study estimates the revenue generated from the sales of companion diagnostics kits and does not include companion diagnostics service revenue. The valuations comprise revenue generated from companion diagnostics that are available for treatment of cancer, CNS disorders, infectious disease, and autoimmune disease. Furthermore, the report also excludes revenue generated from post-sale services of companion diagnostics. For the purpose of analysis, the global companion diagnostics market has been segmented based on technology type, indication, and region. The study estimates the revenue generated from the sales of companion diagnostic kits. On the basis of technology type, the market is categorized into immunohistochemistry, polymerase chain reaction (PCR), next generation sequencing (NGS), in situ hybridization, and others. Based on indication, the market is divided into oncology, neurology, and others. Oncology is further sub-segmented into lung cancer, colorectal cancer, breast cancer, blood cancer, and others. The report covers the revenue generated from the sales of products related to companion diagnostics systems offered in regions such as North America, Europe, Asia-Pacific, and LAMEA.

Hydropower was the RES with the highest installed capacity (49.8 GW) in FY2018 – but it is also the one enjoying the lowest growth rates in India. Further, the share of large hydropower installed capacity in total RES installed capacity dropped below 50% for the first time in FY2016 and was around 40% in FY2018. According to the South Asia Network on Dams, Rivers, and People (“SANDRP”), India’s hydropower output fell below 10% of total electricity generation in India for the second time in FY2018. Large hydropower in India is considered a conventional energy source and, as such, does not receive incentives like other RES. Small hydropower projects are eligible for some financial incentives, as they fall within the RES category. According to the Centre for Financial Accountability (“CENFA”), the public sector has a dominant share of 92.5% in India’s hydropower sector.

Bio-polymers are based partially or completely on natural resources. The raw materials used for the production of bio-polymers include, but not limited to sugar cane, sugar beet, corn starch, potato starch, palm oil, jatropha oil, coconut oil, caster oil, wood pulp, and wheat straw. These raw materials are abundantly available in the developing countries such as Brazil, Thailand etc. In addition, the agricultural land required for the production of these raw materials compared to the available agricultural land is reasonably less.

In Europe, organic farming is practiced primarily due to its social, health, and environmental benefits. Through organic farming, farmers can achieve low emission levels of greenhouse gases, as compared to conventional farming techniques.

定价逻辑：从 “业绩驱动”重弹性 到“ROEROE ”驱动 重龙头 ；从单一 PE 到。